Gianluca Trifiro

Summary

Affiliation: Erasmus MC
Country: The Netherlands

Publications

  1. ncbi Risk of cardiac valve regurgitation with dopamine agonist use in Parkinson's disease and hyperprolactinaemia: a multi-country, nested case-control study
    Gianluca Trifiro
    Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands
    Drug Saf 35:159-71. 2012
  2. ncbi EU-ADR healthcare database network vs. spontaneous reporting system database: preliminary comparison of signal detection
    Gianluca Trifiro
    Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands
    Stud Health Technol Inform 166:25-30. 2011
  3. ncbi Age-related changes in pharmacodynamics: focus on drugs acting on central nervous and cardiovascular systems
    Gianluca Trifiro
    Department of Medical Informatics, Erasmus University Medical Center Dr Molewaterplein 50, 3000 DR, Rotterdam, The Netherlands
    Curr Drug Metab 12:611-20. 2011
  4. ncbi Antipsychotic drug use and community-acquired pneumonia
    Gianluca Trifiro
    Department of Medical Informatics, Erasmus University Medical Center, Dr Molewaterplein 50, 3000 DR, Rotterdam, The Netherlands
    Curr Infect Dis Rep 13:262-8. 2011
  5. ncbi Risk of ischemic stroke associated with antidepressant drug use in elderly persons
    Gianluca Trifiro
    Department of Medical Informatics, Erasmus Medical Center, Rotterdam, The Netherlands
    J Clin Psychopharmacol 30:252-8. 2010
  6. ncbi Association of community-acquired pneumonia with antipsychotic drug use in elderly patients: a nested case-control study
    Gianluca Trifiro
    Erasmus University Medical Center, PO Box 1738, 3000 DR Rotterdam, The Netherlands
    Ann Intern Med 152:418-25, W139-40. 2010
  7. ncbi Prescribing pattern of antipsychotic drugs in the Italian general population 2000-2005: a focus on elderly with dementia
    Gianluca Trifiro
    Department of Clinical and Experimental Medicine and Pharmacology, University of Messina, Italy
    Int Clin Psychopharmacol 25:22-8. 2010
  8. ncbi Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor?
    Gianluca Trifiro
    Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands
    Pharmacoepidemiol Drug Saf 18:1176-84. 2009
  9. ncbi Adherence to gastroprotection during cyclooxygenase 2 inhibitor treatment and the risk of upper gastrointestinal tract events: a population-based study
    Vera E Valkhoff
    Erasmus University Medical Centre, Rotterdam, The Netherlands
    Arthritis Rheum 64:2792-802. 2012
  10. ncbi Prescribing pattern of anti-Parkinson drugs in Southern Italy: cross-sectional analysis in the years 2003-2005
    Gianluca Trifiro
    Department of Clinical and Experimental Medicine and Pharmacology, Pharmacology Unit, University of Messina, Via Consolare Valeria Gazzi, 98125 Messina, Italy
    Parkinsonism Relat Disord 14:420-5. 2008

Detail Information

Publications36

  1. ncbi Risk of cardiac valve regurgitation with dopamine agonist use in Parkinson's disease and hyperprolactinaemia: a multi-country, nested case-control study
    Gianluca Trifiro
    Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands
    Drug Saf 35:159-71. 2012
    ..Cases were patients who developed newly diagnosed CVR. Controls were CVR-free patients from the same cohorts and were matched to cases by age, sex, database and calendar year...
  2. ncbi EU-ADR healthcare database network vs. spontaneous reporting system database: preliminary comparison of signal detection
    Gianluca Trifiro
    Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands
    Stud Health Technol Inform 166:25-30. 2011
    ..The methodology for signal detection in EU-ADR is still under development and testing phase...
  3. ncbi Age-related changes in pharmacodynamics: focus on drugs acting on central nervous and cardiovascular systems
    Gianluca Trifiro
    Department of Medical Informatics, Erasmus University Medical Center Dr Molewaterplein 50, 3000 DR, Rotterdam, The Netherlands
    Curr Drug Metab 12:611-20. 2011
    ..Clinicians should be aware of the age-related physiologic changes affecting several organ systems and their implications on the effect of drugs that are commonly prescribed to elderly patients...
  4. ncbi Antipsychotic drug use and community-acquired pneumonia
    Gianluca Trifiro
    Department of Medical Informatics, Erasmus University Medical Center, Dr Molewaterplein 50, 3000 DR, Rotterdam, The Netherlands
    Curr Infect Dis Rep 13:262-8. 2011
    ..Some general recommendations to clinicians are proposed to prevent the risk of pneumonia in patients requiring antipsychotic treatment...
  5. ncbi Risk of ischemic stroke associated with antidepressant drug use in elderly persons
    Gianluca Trifiro
    Department of Medical Informatics, Erasmus Medical Center, Rotterdam, The Netherlands
    J Clin Psychopharmacol 30:252-8. 2010
    ..To summarize, compared with nonuse, only SSRI use seems to be associated with an increased risk of ischemic stroke in elderly patients, particularly as a short-term effect...
  6. ncbi Association of community-acquired pneumonia with antipsychotic drug use in elderly patients: a nested case-control study
    Gianluca Trifiro
    Erasmus University Medical Center, PO Box 1738, 3000 DR Rotterdam, The Netherlands
    Ann Intern Med 152:418-25, W139-40. 2010
    ..However, epidemiologic evidence of the association between antipsychotic drug use and pneumonia is limited...
  7. ncbi Prescribing pattern of antipsychotic drugs in the Italian general population 2000-2005: a focus on elderly with dementia
    Gianluca Trifiro
    Department of Clinical and Experimental Medicine and Pharmacology, University of Messina, Italy
    Int Clin Psychopharmacol 25:22-8. 2010
    ..Similar trends were not observed in general population and elderly as a whole...
  8. ncbi Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor?
    Gianluca Trifiro
    Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands
    Pharmacoepidemiol Drug Saf 18:1176-84. 2009
    ..Since mining on all possible events was considered to unduly increase the number of spurious signals, we wanted to create a ranked list of high-priority events...
  9. ncbi Adherence to gastroprotection during cyclooxygenase 2 inhibitor treatment and the risk of upper gastrointestinal tract events: a population-based study
    Vera E Valkhoff
    Erasmus University Medical Centre, Rotterdam, The Netherlands
    Arthritis Rheum 64:2792-802. 2012
    ..We undertook this study to determine the association between GPA adherence and UGI tract events among patients receiving coxibs...
  10. ncbi Prescribing pattern of anti-Parkinson drugs in Southern Italy: cross-sectional analysis in the years 2003-2005
    Gianluca Trifiro
    Department of Clinical and Experimental Medicine and Pharmacology, Pharmacology Unit, University of Messina, Via Consolare Valeria Gazzi, 98125 Messina, Italy
    Parkinsonism Relat Disord 14:420-5. 2008
    ..A high proportion of APD users (15-20%) received only one prescription during the study period...
  11. ncbi The risk of new onset heart failure associated with dopamine agonist use in Parkinson's disease
    M Mostafa Mokhles
    Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, Netherlands
    Pharmacol Res 65:358-64. 2012
    ..Among non-ergot dopamine agonists, we observed a statistically significant association between pramipexole use and heart failure, especially during the first months of therapy and in very old patients...
  12. ncbi Combining electronic healthcare databases in Europe to allow for large-scale drug safety monitoring: the EU-ADR Project
    Preciosa M Coloma
    Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands
    Pharmacoepidemiol Drug Saf 20:1-11. 2011
    ..In this proof-of-concept paper we describe the framework, process, and preliminary results of combining data from European electronic healthcare record (EHR) databases for large-scale monitoring of drug safety...
  13. ncbi Electronic healthcare databases for active drug safety surveillance: is there enough leverage?
    Preciosa M Coloma
    Department of Medical Informatics, Erasmus Medical Center, Rotterdam, The Netherlands
    Pharmacoepidemiol Drug Saf 21:611-21. 2012
    ..To provide estimates of the number and types of drugs that can be monitored for safety surveillance using electronic healthcare databases...
  14. ncbi Use and tolerability of newer antipsychotics and antidepressants: a chart review in a paediatric setting
    Marianna Alacqua
    Department of Clinical and Experimental Medicine and Pharmacology, Pharmacology Unit, University of Messina, Via Consolare Valeria Gazzi, 98125 Messina, Italy
    Pharm World Sci 30:44-50. 2008
    ..To analyse the prescribing pattern and the safety profile of different atypical antipsychotics and selective serotonin reuptake inhibitors (SSRIs) during the years 2002-2003 in paediatric setting...
  15. ncbi Antidepressant drugs: prevalence, incidence and indication of use in general practice of Southern Italy during the years 2003-2004
    Gianluca Trifiro
    Department of Clinical and Experimental Medicine and Pharmacology, Pharmacology Unit, University of Messina, Messina, Italy
    Pharmacoepidemiol Drug Saf 16:552-9. 2007
    ..To estimate 1-year prevalence, 1-year incidence and indication of use of antidepressant (AD) drug treatment in general practice of Southern Italy during the years 2003-2004...
  16. ncbi Prescribing pattern of drugs in the treatment of osteoarthritis in Italian general practice: the effect of rofecoxib withdrawal
    Marianna Alacqua
    University of Messina, Messina, Italy
    Arthritis Rheum 59:568-74. 2008
    ..The aim of the present study was to compare the trend of nonsteroidal antiinflammatory drug (NSAID) use and other analgesics in osteoarthritis (OA) treatment before and after rofecoxib withdrawal in Italian general practice...
  17. ncbi All-cause mortality associated with atypical and typical antipsychotics in demented outpatients
    Gianluca Trifiro
    Department of Clinical and Experimental Medicine and Pharmacology, Pharmacology Unit, University of Messina, Italy
    Pharmacoepidemiol Drug Saf 16:538-44. 2007
    ..To estimate the association between use of typical and atypical antipsychotics and all-cause mortality in a population of demented outpatients...
  18. ncbi A reference standard for evaluation of methods for drug safety signal detection using electronic healthcare record databases
    Preciosa M Coloma
    Department of Medical Informatics, Erasmus Medical Center, Postbus 2040, 3000, CA, Rotterdam, The Netherlands
    Drug Saf 36:13-23. 2013
    ..e. list of all known adverse reactions and which drugs can cause them). As there is no true gold standard, prospective evaluation of signal detection methods remains a challenge...
  19. ncbi Prescribing pattern of anti-epileptic drugs in an Italian setting of elderly outpatients: a population-based study during 2004-07
    Alessandro Oteri
    Department of Clinical and Experimental Medicine and Pharmacology, Pharmacology Unit, University of Messina, Via Consolare Valeria, 98125 Messina, Italy
    Br J Clin Pharmacol 70:514-22. 2010
    ....
  20. ncbi A nationwide prospective study on prescribing pattern of antidepressant drugs in Italian primary care
    Gianluca Trifiro
    Department of Clinical and Experimental Medicine and Pharmacology, University of Messina, Via Consolare Valeria Gazzi, 98125, Messina, Italy
    Eur J Clin Pharmacol 69:227-36. 2013
    ..Our purpose was to explore antidepressant drug (AD) prescribing patterns in Italian primary care...
  21. ncbi Use of antipsychotics in elderly patients with dementia: do atypical and conventional agents have a similar safety profile?
    Gianluca Trifiro
    Section of Pharmacology, Department of Clinical and Experimental Medicine and Pharmacology, University of Messina, Italy
    Pharmacol Res 59:1-12. 2009
    ..More effective interventions are necessary to improve postmarket drug safety in vulnerable populations...
  22. ncbi Antipsychotic prescribing pattern among Italian general practitioners: a population-based study during the years 1999-2002
    Gianluca Trifiro
    Department of Clinical and Experimental Medicine, Pharmacology Unit, University of Messina, Via Consolare Valeria Gazzi, 98100 Messina, Italy
    Eur J Clin Pharmacol 61:47-53. 2005
    ..To assess the antipsychotic use and the prevalence/incidence of antipsychotic drug users in Italy during the years 1999-2002. To estimate the persistence with antipsychotic medications, and to measure their off-label use...
  23. ncbi The EU-ADR corpus: annotated drugs, diseases, targets, and their relationships
    Erik M van Mulligen
    Dept of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands
    J Biomed Inform 45:879-84. 2012
    ..These annotated relationships will be used to train and evaluate text-mining software to capture these relationships in texts...
  24. ncbi [ADR-related hospitalization in persons aged 55 years and older in the Netherlands]
    R Ruiter
    Erasmus Medisch Centrum, Rotterdam
    Ned Tijdschr Geneeskd 157:A5182. 2013
    ....
  25. ncbi Using electronic health care records for drug safety signal detection: a comparative evaluation of statistical methods
    Martijn J Schuemie
    Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands
    Med Care 50:890-7. 2012
    ..Drug safety monitoring relies primarily on spontaneous reporting, but electronic health care record databases offer a possible alternative for the detection of adverse drug reactions (ADRs)...
  26. ncbi Adverse drug events in emergency department population: a prospective Italian study
    Gianluca Trifiro
    Department of Clinical and Experimental Medicine, Pharmacology Unit, University of Messina, Messina, Italy
    Pharmacoepidemiol Drug Saf 14:333-40. 2005
    ..We therefore carried out a study to determine ADE incidence and ADE-related hospital admissions among emergency department (ED) visits, and to identify the risk factors for serious ADE leading to ED visit...
  27. ncbi Suboptimal gastroprotective coverage of NSAID use and the risk of upper gastrointestinal bleeding and ulcers: an observational study using three European databases
    Eva M van Soest
    Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands
    Gut 60:1650-9. 2011
    ..It is unknown to what extent the protective effect is influenced by therapy adherence...
  28. ncbi Epidemiology of gout and hyperuricaemia in Italy during the years 2005-2009: a nationwide population-based study
    Gianluca Trifiro
    Correspondence to Gianluca Trifirò, Department of Clinical and Experimental Medicine and Pharmacology, University of Messina, Via Consolare Valeria Gazzi, 98125 Messina, Italy
    Ann Rheum Dis 72:694-700. 2013
    ..To assess the epidemiology of gout and hyperuricaemia in the Italian general population during the years 2005-2009...
  29. ncbi Clinically significant drug interactions with newer antidepressants
    Edoardo Spina
    Section of Pharmacology, Department of Clinical and Experimental Medicine and Pharmacology, University of Messina, Messina, Italy
    CNS Drugs 26:39-67. 2012
    ..Knowledge of the interaction potential of individual antidepressants is essential for safe prescribing and may help clinicians to predict and eventually avoid certain drug combinations...
  30. ncbi Adverse drug reaction-related hospitalizations in persons aged 55 years and over: a population-based study in the Netherlands
    Rikje Ruiter
    Department of Epidemiology, Erasmus MC, Rotterdam, The Netherlands
    Drugs Aging 29:225-32. 2012
    ..However, a recent study conducted in the Netherlands found that ADR-related hospitalizations had stabilized during the years 1997-2007. Nonetheless, this study did not take into account the number of medicines used...
  31. ncbi Postmarketing safety surveillance : where does signal detection using electronic healthcare records fit into the big picture?
    Preciosa M Coloma
    Ee 2116, Department of Medical Informatics, Erasmus Medical Centre, PO Box 2040, 3000 CA, Rotterdam, The Netherlands
    Drug Saf 36:183-97. 2013
    ..Proper evaluation and communication of potential signals identified remains an imperative and should accompany any signal detection activity...
  32. ncbi How much are biosimilars used in southern Italy?: a retrospective analysis of epoetin utilization in the local health unit of Messina in the years 2010-2011
    Chiara Loiacono
    Department of Clinical and Experimental Medicine and Pharmacology, Unit of Pharmacology, University of Messina, Messina, Italy
    BioDrugs 26:113-20. 2012
    ..Epoetins are one of the three biologics for which biosimilars are available in Italy. So far, there is a lack of Italian national/regional longitudinal data about epoetin use...
  33. ncbi Risk minimization activities of centrally authorized products in the EU: a descriptive study
    Inge M Zomerdijk
    Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands
    Drug Saf 35:299-314. 2012
    ..This study describes the additional RMAs of centrally authorized medicinal products authorized between 1 January 1995 and 1 January 2010...
  34. ncbi The EU-ADR project: preliminary results and perspective
    Gianluca Trifiro
    Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands
    Stud Health Technol Inform 148:43-9. 2009
    ..The EU-ADR project aims to exploit different European electronic healthcare records (EHR) databases for drug safety signal detection. In this paper we describe the project framework and the preliminary results...
  35. ncbi Interaction risk with proton pump inhibitors in general practice: significant disagreement between different drug-related information sources
    Gianluca Trifiro
    Department of Clinical and Experimental Medicine and Pharmacology, Pharmacology Unit, University of Messina, Messina, Italy
    Br J Clin Pharmacol 62:582-90. 2006
    ....
  36. ncbi Prescribing pattern of glucose lowering drugs in the United Kingdom in the last decade: a focus on the effects of safety warnings about rosiglitazone
    Ingrid Leal
    Department of Medical Informatics, Erasmus University Medical Center, Rotterdam, The Netherlands
    Br J Clin Pharmacol 75:861-8. 2013
    ..We analyzed the prescription pattern of GLDs from 2000 to November 2009 in the United Kingdom (UK) using the THIN database with special focus on the effects of the safety warnings about rosiglitazone issued in May 2007 and January 2008...